In a nutshell Scientists have solved the 3D structure of EspC, a powerful toxin produced by EPEC, a diarrheal E. coli strain ...

Scientists have taken an important step toward the development of a potential new treatment for treating Shiga ...

The first-of-its-kind in-depth bacterial evolutionary map could pave the way for the development of precision treatments for certain antibiotic-resistant infections, such as urinary tract infections.

from E. coli cells. We incubated purified LT-IL-2 with RPMI 8226 cells and monitored insertion into the membrane by flow cytometry using a PE-labeled antibody against human IL-2. LT-IL-2 could be ...

The device consists of glass capillary tubes with light emitting diode (LED) lights on either end. E. coli antibodies are fixed to the sides of the capillaries and trap any E. coli present in a liquid ...

LBP-EC01 is a bacteriophage ‘cocktail’ that has been modified using CRISPR/Cas3 gene-editing to improve its ability to target the E coli genome. Lab studies have demonstrated it is ...

“I used to work with E. coli for protein expression ... Cell lines commonly used for monoclonal antibody expression include Chinese hamster ovary (CHO) and human embryonic kidney 293 (HEK293 ...

Because we produce recombinantly large amounts of different vascular-related proteins (such as VEGFs, their receptors, antibodies) using E. coli, yeast, insect cells, and mammalian cells, we started ...

“E. coli is a bug that we all have in our intestines,” explains Britain's leading expert on E. coli, the microbiologist Professor Hugh Pennington. “The vast majority of the hundreds of different ...